We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
UBS Group AG | NYSE:UBS | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.7581 | -2.82% | 26.0919 | 26.43 | 26.005 | 26.29 | 757,607 | 18:57:55 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
Date: March 10, 2017
UBS Group AG
Commission File Number: 1-36764
UBS AG
Commission File Number: 1-15060
(Registrants' Names)
Bahnhofstrasse 45, Zurich, Switzerland, and
Aeschenvorstadt 1, Basel, Switzerland
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20‑F or Form 40-F.
Form 20-F x Form 40-F o
This Form 6-K consists of the UBS Group AG audited standalone financial statements for the year ended 31 December 2016, as well as the consent of Ernst & Young Ltd. with respect thereto, which appear immediately following this page.
UBS Group AG
Standalone financial statements for the year ended 31 December 2016
2 |
|
UBS Group AG standalone financial statements |
|
|
|
2 |
|
|
3 |
|
|
4 |
|
|
|
|
|
5 |
1 |
|
6 |
2 |
|
|
|
|
8 |
|
|
8 |
3 |
|
8 |
4 |
|
8 |
5 |
|
8 |
6 |
|
8 |
7 |
|
8 |
8 |
|
|
|
|
9 |
|
|
9 |
9 |
|
9 |
10 |
|
9 |
11 |
|
9 |
12 |
|
10 |
13 |
|
10 |
14 |
|
11 |
15 |
|
11 |
16 |
|
11 |
17 |
|
11 |
18 |
|
12 |
19 |
|
|
|
|
13 |
|
|
13 |
20 |
|
13 |
21 |
|
13 |
22 |
|
14 |
23 |
|
15 |
24 |
|
16 |
25 |
|
|
|
|
17 |
|
|
19 |
|
Independent auditor’s report related to the issue of new shares from conditional capital |
UBS Group AG standalone financial statements
Income statement |
|
|
|
|
|
|
|
|
|
|
|
For the year ended |
|
% change from |
|
CHF million |
|
Note |
|
31.12.16 |
31.12.15 |
|
31.12.15 |
Dividend income from the investment in UBS AG |
|
3 |
|
5,684 |
2,869 |
|
98 |
Other operating income |
|
4 |
|
44 |
49 |
|
(11) |
Financial income |
|
5 |
|
475 |
294 |
|
61 |
Operating income |
|
|
|
6,202 |
3,213 |
|
93 |
Personnel expenses |
|
6 |
|
23 |
9 |
|
146 |
Other operating expenses |
|
7 |
|
35 |
171 |
|
(80) |
Financial expenses |
|
8 |
|
512 |
267 |
|
91 |
Operating expenses |
|
|
|
569 |
447 |
|
27 |
Profit / (loss) before income taxes |
|
|
|
5,633 |
2,765 |
|
104 |
Tax expense / (benefit) |
|
|
|
27 |
9 |
|
201 |
Net profit / (loss) |
|
|
|
5,606 |
2,756 |
|
103 |
1
UBS Group AG standalone financial statements
Balance sheet |
||||||||
|
|
|
|
|
|
|
|
% change from |
CHF million |
|
Note |
|
31.12.16 |
|
31.12.15 |
|
31.12.15 |
|
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
Liquid assets |
|
9 |
|
1,714 |
|
1,442 |
|
19 |
Marketable securities |
|
10 |
|
78 |
|
85 |
|
(8) |
Other short-term receivables |
|
11 |
|
2,830 |
|
632 |
|
348 |
Accrued income and prepaid expenses |
|
12 |
|
469 |
|
264 |
|
78 |
Total current assets |
|
|
|
5,090 |
|
2,422 |
|
110 |
Investments in subsidiaries |
|
13 |
|
40,451 |
|
40,431 |
|
0 |
of which: investment in UBS AG |
|
|
|
40,376 |
|
40,376 |
|
0 |
Financial assets |
|
14 |
|
8,162 |
|
5,475 |
|
49 |
Prepaid assets |
|
|
|
27 |
|
54 |
|
(49) |
Other intangible assets |
|
|
|
21 |
|
0 |
|
|
Total non-current assets |
|
|
|
48,661 |
|
45,959 |
|
6 |
Total assets |
|
|
|
53,751 |
|
48,381 |
|
11 |
of which: amounts due from subsidiaries |
|
|
|
12,762 |
|
7,503 |
|
70 |
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
Current interest-bearing liabilities |
|
|
|
595 |
|
736 |
|
(19) |
Accrued expenses and deferred income |
|
15 |
|
1,487 |
|
1,006 |
|
48 |
Total short-term liabilities |
|
|
|
2,082 |
|
1,741 |
|
20 |
Long-term interest-bearing liabilities |
|
16 |
|
7,865 |
|
5,106 |
|
54 |
Compensation-related long-term liabilities |
|
17 |
|
3,479 |
|
3,119 |
|
12 |
Total long-term liabilities |
|
|
|
11,344 |
|
8,225 |
|
38 |
Total liabilities |
|
|
|
13,427 |
|
9,966 |
|
35 |
of which: amounts due to subsidiaries |
|
|
|
612 |
|
750 |
|
(18) |
|
|
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
|
|
|
Share capital |
|
18 |
|
385 |
|
385 |
|
0 |
General reserves |
|
|
|
34,886 |
|
37,006 |
|
(6) |
of which: statutory capital reserve |
|
|
|
34,886 |
|
37,006 |
|
(6) |
of which: capital contribution reserve |
|
|
|
34,886 |
|
38,035 |
|
(8) |
of which: other capital reserve |
|
|
|
0 |
|
(1,029) |
|
(100) |
Voluntary earnings reserve |
|
|
|
1,716 |
|
(10) |
|
|
Treasury shares |
|
19 |
|
(2,271) |
|
(1,724) |
|
32 |
Reserve for own shares held by subsidiaries |
|
|
|
2 |
|
1 |
|
144 |
Net profit / (loss) |
|
|
|
5,606 |
|
2,756 |
|
103 |
Equity attributable to shareholders |
|
|
|
40,324 |
|
38,415 |
|
5 |
Total liabilities and equity |
|
|
|
53,751 |
|
48,381 |
|
11 |
2
Statement of appropriation of retained earnings and proposed dividend distribution out of capital contribution reserve
The Board of Directors proposes that the Annual General Meeting of Shareholders (AGM) on 4 May 2017 approves the following appropriation of retained earnings.
Proposed appropriation of retained earnings
|
For the year ended |
CHF million |
31.12.16 |
Net profit for the period |
5,606 |
Retained earnings carried forward |
0 |
Total retained earnings available for appropriation |
5,606 |
|
|
Proposed appropriation of retained earnings |
|
Appropriation to voluntary earnings reserve |
(5,606) |
Retained earnings carried forward |
0 |
Proposed dividend distribution out of capital contribution reserve
The Board of Directors proposes that the AGM on 4 May 2017 approves an ordinary dividend distribution of CHF 0.60 in cash per share of CHF 0.10 par value payable out of the capital contribution reserve. Provided that the proposed dividend distribution out of the capital contribution reserve is approved, the payment of CHF 0.60 per share will be made on 10 May 2017 to holders of shares on the record date 9 May 2017. The shares will be traded ex-dividend as of 8 May 2017 and, accordingly, the last day on which the shares may be traded with entitlement to receive the dividend will be 5 May 2017.
3
UBS Group AG standalone financial statements
UBS Group AG is incorporated and domiciled in Switzerland and its registered office is at Bahnhofstrasse 45, CH-8001 Zurich, Switzerland. UBS Group AG operates under the Swiss Code of Obligations as a corporation limited by shares (Aktiengesellschaft), a corporation that has issued shares of common stock to investors.
UBS Group AG is the ultimate holding company of the UBS Group, the grantor of the majority of UBS’s deferred compensation plans, and also issues long-term capital instruments.
Establishment of UBS Group AG
UBS Group AG was incorporated on 10 June 2014 as a wholly owned subsidiary of UBS AG and on 29 September 2014, UBS Group AG launched an offer to acquire all issued ordinary shares of UBS AG. Following the exchange offer and subsequent private exchanges, UBS Group AG acquired 96.68% of UBS AG shares by 31 December 2014.
In March 2015, UBS Group AG initiated a procedure under article 33 of the Swiss Stock Exchange Act (SESTA procedure). After the successful completion of the SESTA procedure in August 2015, UBS Group AG owns 100% of the issued shares of UBS AG.
Transfer of deferred compensation plans
As part of the Group reorganization in 2014, UBS Group AG assumed obligations of UBS AG as grantor in connection with certain outstanding awards under employee share, option, notional fund and deferred cash compensation plans. At the same time, UBS Group AG acquired the beneficial ownership of the financial assets and 90.5 million treasury shares of UBS Group AG held to hedge the economic exposure arising from these plans. As a result of the transfer, UBS Group AG assumed all responsibilities and rights associated with the grantor role for these plans from UBS AG, including the right of recharge to its subsidiaries employing the personnel.
Obligations relating to deferred compensation plans which are required to be, and have been, granted by employing and / or sponsoring subsidiaries have not been assumed by UBS Group AG and continue on this basis. Furthermore, obligations related to other compensation awards, such as defined benefit pension plans and other local awards, have not been assumed by UBS Group AG and are retained by the relevant employing and / or sponsoring subsidiaries.
Issuance of additional tier 1 capital instruments
During 2016, UBS Group AG continued to issue perpetual capital notes, which qualify as Basel III additional tier 1 (AT1) capital on a consolidated UBS Group basis. The proceeds from the issuances of those instruments were on-lent to UBS AG for funding purposes.
® Refer to Note 16 for more information on the main terms and conditions of the perpetual capital notes issued during 2016 and 2015
Furthermore, UBS Group AG granted Deferred Contingent Capital Plan (DCCP) awards to UBS Group employees during 2016 and 2015. These DCCP awards also qualify as Basel III AT1 capital on a consolidated UBS Group basis.
As of 31 December 2016, UBS Group AG ’ s distributable items for the purpose of additional tier 1 capital instruments were CHF 39.9 billion (31 December 2015: CHF 38.0 billion). For this purpose, distributable items are defined in the terms and conditions of the relevant instruments as the aggregate of (i) net profits carried forward and (ii) freely distributable reserves, in each case, less any amounts that must be contributed to legal reserves under applicable law.
4
The UBS Group AG standalone financial statements are prepared in accordance with the principles of the Swiss Law on Accounting and Financial Reporting (32nd title of the Swiss Code of Obligations).
The functional currency of UBS Group AG is the Swiss franc. The significant accounting and valuation principles applied are described below.
Foreign currency translation
Transactions denominated in foreign currency are translated into Swiss francs at the spot exchange rate on the date of the transaction. At the balance sheet date, all current assets and short-term liabilities as well as Financial assets measured at fair value, which are denominated in a foreign currency, are translated into Swiss francs using the closing exchange rate. For other non-current assets and long-term liabilities, where the asset mirrors the terms of a corresponding liability or the asset and liability otherwise form an economic hedge relationship, the asset and liability are treated as one unit of account for foreign currency translation purposes, with offsetting unrealized foreign currency translation gains and losses based on the closing exchange rate presented net in the income statement. Investments in subsidiaries measured at historic cost are translated at the spot exchange rate on the date of the transaction. All currency translation effects are recognized in the income statement.
The main currency translation rates used by UBS Group AG are provided in Note 34 to the consolidated financial statements.
Marketable securities
Marketable securities include investments in alternative investment vehicles (AIVs) with a short-term holding period. The holding period is deemed short-term if the vesting of the awards hedged by the AIV is within 12 months after the balance sheet date. These are equity instruments and are measured at fair value based on quoted market prices or other observable market prices as of the balance sheet date. Gains and losses resulting from fair value changes are recognized in Financial income and Financial expenses, respectively.
Financial assets
Financial assets include investments in AIVs with a long-term holding period. The holding period is deemed long-term if the vesting of the awards hedged by the AIV is more than 12 months after the balance sheet date. These are equity instruments and are measured at fair value based on their quoted market prices or other observable market prices as of the balance sheet date. Gains and losses resulting from fair value changes are recognized in Financial income and Financial expenses, respectively.
Investments in AIVs that have no quoted market price or no other observable market price are recognized as Financial assets and are measured at their acquisition cost adjusted for impairment losses.
Financial assets further include loans granted to UBS AG which substantially mirror the terms of additional tier 1 perpetual capital notes issued. The loans are measured at nominal value.
® Refer to Note 14 for more information
Investments in subsidiaries
Investments in subsidiaries are equity interests that are held to carry on the business of UBS Group or for other strategic purposes. They include all subsidiaries directly held by UBS Group AG through which UBS conducts its business on a global basis. The investments are measured individually and carried at cost less impairment.
® Refer to Note 13 for more information
® Refer to Note 2 in the “Consolidated financial statements” section of this report for a description of businesses of the UBS Group
Treasury shares
Treasury shares acquired by UBS Group AG are recognized at acquisition cost and are presented as a deduction from shareholders’ equity. Upon disposal or settlement of related share awards, the realized gain or loss is recognized through the income statement as Financial income and Financial expenses , respectively. For settlement of related share awards, the realized gains and losses on treasury shares represent the difference between the market price of the treasury shares at settlement and their acquisition cost.
For shares of UBS Group AG acquired by a direct or indirect subsidiary, a Reserve for own shares held by subsidiaries is generally created in UBS Group AG’s equity. However, where UBS AG or UBS Switzerland AG acquire shares of UBS Group AG and hold them in their trading portfolios, no Reserve for own shares held by subsidiaries is created.
® Refer to Note 19 for more information
5
UBS Group AG standalone financial statements
Note 2 Accounting policies (continued)
Equity participation and other compensation plans
Transfer from UBS AG to UBS Group AG
The transfer of the deferred compensation plans and related hedging assets in 2014 was conducted on an arm’s length basis, with a step-up of the plan obligation to fair value. This step-up resulted in a net liability that was recorded in the standalone financial statements of UBS AG and transferred to UBS Group AG (net liability related to deferred compensation plan transfer) in 2014. The fair value of this net liability is taken into account in the income statement over the average vesting period (for share awards) or upon exercise / expiry (for option awards) as Other operating income. Upon exercise of option awards that are settled using conditional capital, the fair value of this net liability is recorded in the Statutory capital reserve within General reserves. The difference between the fair value of the hedging assets and the fair value of the obligations on the plans transferred was compensated for with a loan from UBS AG to UBS Group AG.
Equity participation plans
The grant date fair value of equity-settled share-based compensation awards granted to employees is generally recognized over the vesting period of the awards. Awards granted in the form of UBS Group AG shares and notional shares are settled by delivering UBS Group AG shares at vesting and are recognized as Compensation-related long-term liabilities if vesting is more than 12 months after the balance sheet date or as Accrued expenses and deferred income if vesting is within 12 months from the balance sheet date. The amount recognized is adjusted for forfeiture assumptions, such that the amount ultimately recognized is based on the number of awards that meet the related service conditions at the vesting date. The grant date fair value is based on the UBS Group AG share price, taking into consideration post-vesting sale and hedge restrictions, non-vesting conditions and market conditions, where applicable.
Upon settlement of the share awards, any realized gain or loss is recognized in the income statement as Other operating income and Other operating expenses, respectively. Realized gains and losses on share awards represent the difference between the market price of the treasury shares at settlement and the grant date fair value of the share awards.
For certain awards, employees receive beneficial and legal ownership of the underlying UBS Group AG shares at the grant date (prepaid awards). Such prepaid awards are recognized as Prepaid assets if vesting is more than 12 months after the balance sheet date or as Accrued income and prepaid expenses if vesting is within 12 months from the balance sheet date.
Shares awarded to employees that are settled using conditional capital are accounted for as follows at settlement: the amount paid by the employees for the nominal value of the shares awarded is recorded in Share capital , while any paid amount exceeding the nominal value is considered to be share premium and is recorded in the Statutory capital reserve within General reserves.
Other compensation plans
Deferred compensation plans that are not share-based, including DCCP awards and awards in the form of AIVs, are accounted for as cash-settled awards. The present value or fair value of the amount payable to employees that is settled in cash is recognized as a liability generally over the vesting period, as Compensation-related long-term liabilities if vesting is more than 12 months after the balance sheet date and as Accrued expenses and deferred income if vesting is within 12 months from the balance sheet date. The liabilities are remeasured at each balance sheet date at the present value of the corresponding DCCP award and the fair value of investments in AIVs, respectively. Gains and losses resulting from remeasurement of the liabilities are recognized in Other operating income and Other operating expenses , respectively.
Recharge of compensation expenses
Expenses related to deferred compensation plans are recharged by UBS Group AG to its subsidiaries employing the personnel. Upon recharge, UBS Group AG recognizes a receivable from its subsidiaries corresponding to a liability representing its obligation toward employees.
Dispensations in the standalone financial statements
As UBS Group AG prepares consolidated financial statements in accordance with IFRS, UBS Group AG is exempt from various disclosures in the standalone financial statements. The dispensations include the management report and the statement of cash flows, as well as certain note disclosures.
6
Dividend income received from UBS AG in 2016 consists of CHF 3,434 million related to the financial year ended 31 December 2015, which was approved by the Annual General Meeting of Shareholders of UBS AG on 4 May 2016, and CHF 2,250 million related to the financial year ended 31 December 2016, which was approved by the Annual General Meeting of Shareholders of UBS AG on 2 March 2017.
|
|
For the year ended |
|
% change from |
||
CHF million |
|
31.12.16 |
|
31.12.15 |
|
31.12.15 |
Fair value gains on alternative investment vehicles awards |
|
6 |
|
13 |
|
(57) |
Gains related to equity-settled awards |
|
24 |
|
29 |
|
(18) |
Amortization of net liability related to deferred compensation plan transfer |
|
2 |
|
6 |
|
(64) |
Commission income from guarantees issued |
|
12 |
|
1 |
|
813 |
Total other operating income |
|
44 |
|
49 |
|
(11) |
|
|
For the year ended |
|
% change from |
||
CHF million |
|
31.12.16 |
|
31.12.15 |
|
31.12.15 |
Treasury share gains |
|
0 |
|
32 |
|
(100) |
Interest income on long-term receivables from UBS AG |
|
470 |
|
253 |
|
86 |
Foreign currency translation gains |
|
4 |
|
10 |
|
(58) |
Total financial income |
|
475 |
|
294 |
|
61 |
Personnel expenses include recharges from UBS AG for personnel-related costs for activities performed by UBS AG personnel for the benefit of UBS Group AG.
UBS Group AG had no employees throughout 2016 and 2015. All employees of the UBS Group, including the members of the Group Executive Board (GEB) of UBS Group AG, were employed by subsidiaries of UBS Group AG. As of 31 December 2016, the UBS Group employed 59,387 personnel (31 December 2015: 60,099) on a full-time equivalent basis.
Note 7 Other operating expenses
|
|
For the year ended |
|
% change from |
||
CHF million |
|
31.12.16 |
|
31.12.15 |
|
31.12.15 |
Losses related to equity-settled awards |
|
3 |
|
147 |
|
(98) |
Capital tax |
|
13 |
|
13 |
|
(1) |
Stamp tax |
|
0 |
|
1 |
|
(75) |
Other |
|
18 |
|
11 |
|
71 |
Total other operating expenses |
|
35 |
|
171 |
|
(80) |
|
|
For the year ended |
|
% change from |
||
CHF million |
|
31.12.16 |
|
31.12.15 |
|
31.12.15 |
Fair value losses on marketable securities and financial assets |
|
3 |
|
12 |
|
(77) |
Impairment losses on financial assets |
|
3 |
|
1 |
|
322 |
Treasury share losses |
|
35 |
|
0 |
|
|
Interest expense on interest-bearing liabilities |
|
469 |
|
255 |
|
84 |
Brokerage fees paid |
|
2 |
|
0 |
|
|
Total financial expenses |
|
512 |
|
267 |
|
91 |
7
UBS Group AG standalone financial statements
Liquid assets comprise current accounts held at UBS Switzerland AG.
Marketable securities include investments in AIVs related to compensation awards vesting within 12 months after the balance sheet date.
As of 31 December 2016, other short-term receivables were mainly comprised of a CHF 2,250 million dividend receivable from UBS AG related to the financial year ended 31 December 2016 and CHF 557 million in receivables from employing entities related to compensation awards. As of 31 December 2015, other short-term receivables were mainly comprised of CHF 632 million in receivables from employing entities related to compensation awards.
Note 12 Accrued income and prepaid expenses
|
|
|
|
|
|
% change from |
CHF million |
|
31.12.16 |
|
31.12.15 |
|
31.12.15 |
Accrued interest income |
|
375 |
|
257 |
|
46 |
Other prepaid expenses |
|
93 |
|
7 |
|
|
Total accrued income and prepaid expenses |
|
469 |
|
264 |
|
78 |
8
Unless otherwise stated, the subsidiaries listed in the tables below have share capital consisting solely of ordinary shares, which are held by UBS Group AG or UBS AG, respectively. The proportion of ownership interest held is equal to the voting rights held by UBS Group AG or UBS AG, respectively. The country where the respective registered office is located is also the principal place of business. UBS AG operates through a global network of branches and a significant proportion of its business activity is conducted outside Switzerland in the UK, US, Asia Pacific and other countries. UBS Europe SE has branches and offices in a number of EU member states, including branches in Germany, Italy, Luxembourg and Spain.
Individually significant subsidiaries of UBS AG are those entities that contribute significantly to the Group’s financial position or results of operations, based on a number of criteria, including the subsidiaries’ equity and their contribution to the Group’s total assets and profit or loss before tax, in accordance with Swiss regulations.
During 2016, the majority of the operating subsidiaries of Asset Management were transferred to UBS Asset Management AG to create a holding structure spanning the division’s global activities outside the US. Also in 2016 , UBS AG’s direct Wealth Management subsidiaries UBS (Italia) SpA, UBS (Luxembourg) S.A. (including its branches in Austria, Denmark and Sweden), UBS Bank S.A. (Madrid) and UBS Bank (Netherlands) B.V. were merged into UBS Deutschland AG, which was renamed to UBS Europe SE and is headquartered in Frankfurt, Germany.
UBS Americas Holding LLC, UBS Asset Management AG, UBS Europe SE, UBS Limited and UBS Switzerland AG are fully held by UBS AG. UBS Bank USA, UBS Financial Services Inc. and UBS Securities LLC are fully held, directly or indirectly, by UBS Americas Holding LLC.
® Refer to Note 28 in the “Consolidated financial statements” section of this report for more information
|
|
|
|
|
|
% change from |
CHF million |
|
31.12.16 |
|
31.12.15 |
|
31.12.15 |
Long-term receivables from UBS AG¹ |
|
7,865 |
|
5,171 |
|
52 |
Investments in alternative investment vehicles at fair value related to awards vesting after 12 months |
|
291 |
|
294 |
|
(1) |
Investments in alternative investment vehicles at cost less impairment |
|
6 |
|
9 |
|
(33) |
Total financial assets |
|
8,162 |
|
5,475 |
|
49 |
1 Long-term receivables from UBS AG include the onward lending of the proceeds from the issuances of additional tier 1 perpetual capital notes. |
9
UBS Group AG standalone financial statements
Note 15 Accrued expenses and deferred income
|
|
|
|
|
|
% change from |
CHF million |
|
31.12.16 |
|
31.12.15 |
|
31.12.15 |
Short-term portion of net liability related to deferred compensation plan transfer |
|
1 |
|
2 |
|
(70) |
Short-term portion of compensation liabilities |
|
1,048 |
|
720 |
|
46 |
of which: Deferred Contingent Capital Plan |
|
93 |
|
65 |
|
44 |
of which: other deferred compensation plans |
|
955 |
|
655 |
|
46 |
Accrued interest expense |
|
374 |
|
255 |
|
46 |
Other |
|
65 |
|
29 |
|
126 |
Total accrued expenses and deferred income |
|
1,487 |
|
1,006 |
|
48 |
Note 16 Long-term interest-bearing liabilities
Notes issued, overview by amount, maturity and coupon |
|
31.12.16 |
|
|
|
|
31.12.15 |
|||
in million, except where indicated |
|
|
Carrying value in transaction currency |
Carrying value in CHF |
|
Maturity¹ |
Coupon¹ |
|
Carrying value in transaction currency |
Carrying value in CHF |
Euro-denominated low-trigger loss-absorbing additional tier 1 perpetual capital notes |
|
|
1,000 |
1,071 |
|
19.02.22 |
5.750% |
|
988 |
1,075 |
US dollar-denominated low-trigger loss-absorbing additional tier 1 perpetual capital notes |
|
|
1,250 |
1,272 |
|
19.02.25 |
7.000% |
|
1,234 |
1,236 |
US dollar-denominated high-trigger loss-absorbing additional tier 1 perpetual capital notes |
|
|
1,250 |
1,272 |
|
19.02.20 |
7.125% |
|
1,234 |
1,236 |
US dollar-denominated high-trigger loss-absorbing additional tier 1 perpetual capital notes |
|
|
1,575 |
1,603 |
|
07.08.25 |
6.875% |
|
1,555 |
1,558 |
US dollar-denominated high-trigger loss-absorbing additional tier 1 perpetual capital notes |
|
|
1,500 |
1,527 |
|
22.03.21 |
6.875% |
|
|
|
US dollar-denominated high-trigger loss-absorbing additional tier 1 perpetual capital notes |
|
|
1,100 |
1,120 |
|
10.08.21 |
7.125% |
|
|
|
Total long-term interest-bearing liabilities |
|
|
|
7,865 |
|
|
|
|
|
5,106 |
1 The disclosed maturity refers to the optional first call date of the respective issuance and the disclosed coupon refers to the fixed coupon rate from the issue date up to, but excluding, the optional first call date. |
Note 17 Compensation-related long-term liabilities
|
|
|
|
|
|
% change from |
CHF million |
|
31.12.16 |
|
31.12.15 |
|
31.12.15 |
Long-term portion of net liability related to deferred compensation plan transfer |
|
10 |
|
11 |
|
(11) |
Long-term portion of compensation liabilities |
|
3,469 |
|
3,107 |
|
12 |
of which: Deferred Contingent Capital Plan |
|
1,532 |
|
1,109 |
|
38 |
of which: other deferred compensation plans |
|
1,937 |
|
1,999 |
|
(3) |
Total compensation-related long-term liabilities |
|
3,479 |
|
3,119 |
|
12 |
On 31 December 2016 , the issued share capital consisted of 3,850,766,389 (31 December 2015: 3,849,731,535) registered shares at a par value of CHF 0.10 each.
® Refer to the “UBS shares” section of this report for more information on UBS Group AG shares
10
|
Number of registered shares |
Average price in CHF |
Balance as of 31 December 2014 |
87,871,737 |
16.94 |
of which: treasury shares held by UBS Group AG |
90,176,988 |
16.95 |
of which: short sales of treasury shares by UBS AG and other subsidiaries |
(2,305,251) |
17.30 |
Share-for-share exchange |
(100,923) |
19.90 |
Acquisitions |
89,594,586 |
17.57 |
Disposals |
(27,510,789) |
17.08 |
Delivery of shares to settle equity-settled awards |
(51,148,336) |
17.29 |
Balance as of 31 December 2015 |
98,706,275 |
17.51 |
of which: treasury shares held by UBS Group AG¹ |
98,465,708 |
17.50 |
of which: treasury shares held by UBS AG and other subsidiaries |
240,567 |
19.51 |
Acquisitions |
90,448,847 |
15.49 |
Disposals |
(2,721,710) |
17.82 |
Delivery of shares to settle equity-settled awards |
(47,991,640) |
16.86 |
Balance as of 31 December 2016 |
138,441,772 |
16.41 |
of which: treasury shares held by UBS Group AG¹ |
138,386,307 |
16.41 |
of which: treasury shares held by UBS AG and other subsidiaries |
55,465 |
16.06 |
1 Treasury shares held by UBS Group AG had a carrying value of CHF 2,271 million as of 31 December 2016 (31 December 2015: CHF 1,724 million). |
11
UBS Group AG standalone financial statements
As of 31 December 2016, UBS Group AG had issued senior unsecured debt through its subsidiary UBS Group Funding (Jersey) Ltd for a nominal amount equivalent to CHF 17,281 million (31 December 2015: CHF 5,668 million). This debt contributes to the total loss-absorbing capacity (TLAC) of the Group. UBS Group AG issued guarantees to the external investors against any default in payments of interest and principal by UBS Group Funding (Jersey) Ltd.
As of 31 December 2016, total pledged assets of UBS Group AG amounted to CHF 4,134 million. These assets consisted of certain liquid assets, marketable securities and financial assets and were pledged to UBS AG. As of 31 December 2015, total pledged assets of UBS Group AG amounted to CHF 41,835 million and primarily consisted of the investment in UBS AG. The associated liabilities secured by these pledged assets were CHF 524 million and CHF 581 million as of 31 December 2016 and 31 December 2015, respectively.
UBS Group AG is jointly and severally liable for the combined value added tax (VAT) liability of UBS entities that belong to the VAT group of UBS in Switzerland.
12
Shareholders registered in the UBS Group AG share register with 3% or more of total share capital |
||
% of share capital |
31.12.16 |
31.12.15 |
Chase Nominees Ltd., London |
9.43 |
9.14 |
GIC Private Limited, Singapore |
|
6.38 |
DTC (Cede & Co.), New York¹ |
6.62 |
6.14 |
Nortrust Nominees Ltd., London |
3.88 |
3.60 |
1 DTC (Cede & Co.), New York, “The Depository Trust Company,” is a US securities clearing organization. |
Under the Swiss Federal Act on Financial Market Infrastructures and Market Conduct in Securities and Derivatives Trading of 19 June 2015 (FMIA), anyone holding shares in a company listed in Switzerland, or holding derivative rights related to shares of such a company, must notify the company and the SIX Swiss Exchange (SIX) if the holding reaches, falls below or exceeds one of the following thresholds: 3, 5, 10, 15, 20, 25, 33 1 ⁄ 3 , 50, or 66 2 ⁄ 3 % of voting rights, regardless of whether or not such rights may be exercised. The detailed disclosure requirements and the methodology for calculating the thresholds are defined in the Swiss Financial Market Supervisory Authority Ordinance on Financial Market Infrastructure (FMIO-FINMA). In particular, the FMIO-FINMA sets forth that nominee companies that cannot autonomously decide how voting rights are exercised are not obligated to notify the company and SIX if they reach, exceed or fall below the threshold percentages.
In addition, pursuant to the Swiss Code of Obligations, UBS must disclose in the Notes to its financial statements the identity of any shareholder with a holding of more than 5% of the total share capital of UBS Group AG.
According to disclosure notifications filed with UBS Group AG and the SIX under the applicable Swiss rules, GIC Private Limited disclosed on 10 December 2014 a holding of 7.07% of the total share capital of UBS Group AG. The beneficial owner of this holding is the Government of Singapore. On 10 December 2014, Norges Bank, Oslo, the Central Bank of Norway, disclosed a holding of 3.30%. On 15 January 2015, BlackRock Inc., New York, disclosed a holding of 4.89%. On 10 February 2016, MFS Investment Management, Boston, disclosed a holding of 3.05%, and on 16 November 2016, The Capital Group Companies, Inc., Los Angeles, disclosed a holding of 3.01%.
In accordance with the FMIA, the aforementioned percentages were holdings that are not necessarily also registered in the UBS share register and calculated in relation to the total share capital of UBS Group AG reflected in the AoA at the time of the respective disclosure notification. Information on disclosures under the FMIA is available at www.six-exchange-regulation.com/en/home/publications/significant-shareholders.html .
According to the share register, the shareholders (acting in their own name or in their capacity as nominees for other investors or beneficial owners) listed in the table above were registered in the UBS share register with 3% or more of the total share capital of UBS Group AG as of 31 December 2016 or as of 31 December 2015.
Cross-shareholdings
We have no cross-shareholdings in excess of a reciprocal ownership of 5% of capital or voting rights with any other company.
13
UBS Group AG standalone financial statements
Note 24 Share and option ownership of the members of the Board of Directors, the Group Executive Board and other employees
Shares awarded |
|
|
|
|
|
|
|
|
For the year ended 31.12.16 |
|
For the year ended 31.12.15 |
||
|
|
Number of shares |
Value of shares in CHF million |
|
Number of shares |
Value of shares in CHF million |
Awarded to members of the BoD |
|
411,962 |
6 |
|
425,258 |
7 |
Awarded to members of the GEB |
|
2,572,329 |
39 |
|
2,230,800 |
37 |
Awarded to other UBS Group employees |
|
79,900,730 |
1,107 |
|
64,213,472 |
1,042 |
Total |
|
82,885,021 |
1,152 |
|
66,869,530 |
1,087 |
® Refer to the “Corporate governance, responsibility and compensation” section in this report for more information on the terms and conditions of the shares and options awarded to the members of the Board of Directors and the Group Executive Board
14
Note 24 Share and option ownership of the members of the Board of Directors, the Group Executive Board and other employees (continued)
Share and option ownership / entitlements of GEB members¹ |
|||||||
Name, function |
on 31 December |
Number of unvested shares / at risk² |
Number of vested shares |
Total number of shares |
Potentially conferred voting rights in % |
Number of options³ |
Potentially conferred voting rights in %⁴ |
Sergio P. Ermotti, Group Chief Executive Officer |
2016 |
1,365,537 |
265,515 |
1,631,052 |
0.097 |
0 |
0.000 |
2015 |
947,964 |
155,736 |
1,103,700 |
0.059 |
0 |
0.000 |
|
Martin Blessing, President Personal & Corporate Banking and President UBS Switzerland |
2016 |
0 |
0 |
0 |
0.000 |
0 |
0.000 |
2015 |
– |
– |
– |
|
– |
|
|
Christian Bluhm, Group Chief Risk Officer |
2016 |
0 |
0 |
0 |
0.000 |
0 |
0.000 |
2015 |
– |
– |
– |
|
– |
|
|
Markus U. Diethelm, Group General Counsel |
2016 |
538,520 |
154,820 |
693,340 |
0.041 |
0 |
0.000 |
2015 |
447,694 |
61,797 |
509,491 |
0.027 |
0 |
0.000 |
|
Lukas Gähwiler, former President Personal & Corporate Banking and President UBS Switzerland |
2016 |
– |
– |
– |
|
– |
|
2015 |
558,657 |
1,515 |
560,172 |
0.030 |
0 |
0.000 |
|
Kirt Gardner, Group Chief Financial Officer |
2016 |
142,646 |
38,581 |
181,227 |
0.011 |
0 |
0.000 |
2015 |
– |
– |
– |
|
– |
|
|
Sabine Keller-Busse, Group Head Human Resources |
2016 |
200,272 |
120,897 |
321,169 |
0.019 |
0 |
0.000 |
2015 |
– |
– |
– |
|
– |
|
|
Ulrich Körner, President Asset Management and President UBS EMEA |
2016 |
797,165 |
95,597 |
892,762 |
0.053 |
0 |
0.000 |
2015 |
642,813 |
95,597 |
738,410 |
0.039 |
0 |
0.000 |
|
Axel P. Lehmann, Group Chief Operating Officer |
2016 |
0 |
277,978 |
277,978 |
0.017 |
0 |
0.000 |
2015 |
– |
– |
– |
|
– |
|
|
Tom Naratil, President Wealth Management Americas and President UBS Americas |
2016 |
838,193 |
352,634 |
1,190,827 |
0.071 |
412,917 |
0.025 |
2015 |
598,172 |
310,054 |
908,226 |
0.049 |
555,115 |
0.030 |
|
Andrea Orcel, President Investment Bank |
2016 |
1,203,535 |
207,114 |
1,410,649 |
0.084 |
0 |
0.000 |
2015 |
933,686 |
117,646 |
1,051,332 |
0.056 |
0 |
0.000 |
|
Kathryn Shih, President UBS Asia Pacific |
2016 |
567,777 |
0 |
567,777 |
0.034 |
143,869 |
0.009 |
2015 |
– |
– |
– |
|
– |
|
|
Jürg Zeltner, President Wealth Management |
2016 |
881,976 |
1,075 |
883,051 |
0.053 |
64,164 |
0.004 |
2015 |
683,767 |
3,721 |
687,488 |
0.037 |
86,279 |
0.005 |
|
Total |
2016 |
6,535,621 |
1,514,211 |
8,049,832 |
0.479 |
620,950 |
0.037 |
2015 |
6,747,010 |
1,677,989 |
8,424,999 |
0.450 |
1,401,686 |
0.075 |
|
1 Includes all vested and unvested shares and options of GEB members, including those held by related parties. 2 Includes shares granted under variable compensation plans with forfeiture provisions. The actual number of shares vesting in the future will be calculated under the terms of the plans. Refer to the “Our deferred variable compensation plans for 2016” in the “Compensation” section of this report for more information on the plans. 3 Refer to “Note 27 Equity participation and other compensation plans” in the “Consolidated financial statements” section of this report for more information. 4 No conversion rights outstanding. |
Related parties are defined under the Swiss Code of Obligations as direct and indirect participants with voting rights of 20% or more, management bodies (BoD and GEB), external auditors and direct and indirect investments in subsidiaries. Payables due to members of the GEB are provided in the table below. Amounts due from and due to subsidiaries are provided on the face of the balance sheet.
|
|
|
|
|
|
% change from |
CHF million |
|
31.12.16 |
|
31.12.15 |
|
31.12.15 |
Payables due to the members of the GEB |
|
119 |
|
139 |
|
(14) |
of which: Deferred Contingent Capital Plan |
|
51 |
|
53 |
|
(4) |
of which: other deferred compensation plans |
|
68 |
|
86 |
|
(21) |
▲
15
16
17
19
This Form 6-K is hereby incorporated by reference into (1) each of the registration statements of UBS AG on Form F-3 (Registration Number 333-204908) and of UBS Group AG on Form S-8 (Registration Numbers 333-200634; 333-200635; 333-200641; 333-200665; 333-215254; and 333-215255), and into each prospectus outstanding under any of the foregoing registration statements, (2) any outstanding offering circular or similar document issued or authorized by UBS AG that incorporates by reference any Form 6-K’s of UBS 111572), the AG that are incorporated into its registration statements filed with the SEC, and (3) the base prospectus of Corporate Asset Backed Corporation (“CABCO”) dated June 23, 2004 (Registration Number 333- Form 8-K of CABCO filed and dated June 23, 2004 (SEC File Number 001-13444), and the Prospectus Supplements relating to the CABCO Series 2004-101 Trust dated May 10, 2004 and May 17, 2004 (Registration Number 033-91744 and 033-91744-05).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
UBS Group AG
By: _/s/ Todd Tuckner ___________
Name: Todd Tuckner
Title: Group Controller and
Chief Accounting Officer
By: _/s/ David Kelly _____________
Name: David Kelly
Title: Managing Director
UBS AG
By: _/s/ Todd Tuckner ___________
Name: Todd Tuckner
Title: Group Controller and
Chief Accounting Officer
By: _/s/ David Kelly _____________
Name: David Kelly
Title: Managing Director
Date: March 10, 2017
1 Year UBS Chart |
1 Month UBS Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions